Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Current Cancer Drug Targets
|
July 10, 2024
The Imidazacridine Derivative LPSF/AC-05 Induces Apoptosis, Cell Cycle Arrest, and Topoisomerase II Inhibition in Breast Cancer, Leukemia, and Lymphoma
Mardonny Bruno de Oliveira Chagas, Valecia de Cassia Mendonca da Costa, Claudio Montenegro, et al.
Inflammopharmacology
|
May 10, 2019
Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients
Anderson Rodrigues de Almeida, Andréa Tavares Dantas, Michelly Cristiny Pereira, et al.
Immunobiology
|
June 11, 2020
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
Anderson Rodrigues de Almeida, Andréa Tavares Dantas, Michelly Cristiny Pereira, et al.
Immunobiology
|
February 14, 2020
Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis
Priscilla Stela Santana de Oliveira, Adson Belém Ferreira da Paixão, Laurindo Ferreira da Rocha Junior, et al.
Clinical Rheumatology
|
July 11, 2015
Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement
Andréa Tavares Dantas, Sayonara Maria Calado Gonçalves, Michelly Cristiny Pereira, et al.
Autoimmunity
|
June 10, 2015
Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29)
Andréa Tavares Dantas, Sayonara Maria Calado Gonçalves, Michelly Cristiny Pereira, et al.
Journal of Cancer Research and Clinical Oncology
|
October 16, 2023
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer
Rodrigo Santiago Moreira, Marillya Morais da Silva, César Freire de Melo Vasconcelos, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 2, 2025
Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis
Eudes Gustavo Constantino Cunha, Anderson Rodrigues de Almeida, Andréa Tavares Dantas, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 15, 2014
Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis
Michelly Cristiny Pereira, Pablo Ramon Gualberto Cardoso, Laurindo Ferreira Da Rocha, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 21, 2024
Induction of SK-MEL-28 Invasion by Brain Cortical Cell-Conditioned Medium Through CXCL10 Signaling
Maria Clara Pinheiro Duarte Sampaio, Renata Virgínia Cavalcanti Santos, Amanda Pinheiro de Barros Albuquerque, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Current Cancer Drug Targets
|
July 10, 2024
The Imidazacridine Derivative LPSF/AC-05 Induces Apoptosis, Cell Cycle Arrest, and Topoisomerase II Inhibition in Breast Cancer, Leukemia, and Lymphoma
Mardonny Bruno de Oliveira Chagas, Valecia de Cassia Mendonca da Costa, Claudio Montenegro, et al.
Inflammopharmacology
|
May 10, 2019
Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients
Anderson Rodrigues de Almeida, Andréa Tavares Dantas, Michelly Cristiny Pereira, et al.
Immunobiology
|
June 11, 2020
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
Anderson Rodrigues de Almeida, Andréa Tavares Dantas, Michelly Cristiny Pereira, et al.
Immunobiology
|
February 14, 2020
Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis
Priscilla Stela Santana de Oliveira, Adson Belém Ferreira da Paixão, Laurindo Ferreira da Rocha Junior, et al.
Clinical Rheumatology
|
July 11, 2015
Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement
Andréa Tavares Dantas, Sayonara Maria Calado Gonçalves, Michelly Cristiny Pereira, et al.
Autoimmunity
|
June 10, 2015
Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29)
Andréa Tavares Dantas, Sayonara Maria Calado Gonçalves, Michelly Cristiny Pereira, et al.
Journal of Cancer Research and Clinical Oncology
|
October 16, 2023
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer
Rodrigo Santiago Moreira, Marillya Morais da Silva, César Freire de Melo Vasconcelos, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 2, 2025
Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis
Eudes Gustavo Constantino Cunha, Anderson Rodrigues de Almeida, Andréa Tavares Dantas, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 15, 2014
Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis
Michelly Cristiny Pereira, Pablo Ramon Gualberto Cardoso, Laurindo Ferreira Da Rocha, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 21, 2024
Induction of SK-MEL-28 Invasion by Brain Cortical Cell-Conditioned Medium Through CXCL10 Signaling
Maria Clara Pinheiro Duarte Sampaio, Renata Virgínia Cavalcanti Santos, Amanda Pinheiro de Barros Albuquerque, et al.
Page
of 7